-
RxSight ( NASDAQ: RXST ) on Tuesday announced that it intends to offer and sell $40.0 million of shares of its common stock in an underwritten public offering.
-
RxSight expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering on the same terms and conditions.
-
RxSight intends to use the net proceeds of the offering for continued commercial and marketing expansion, funding of product development, research and clinical development, and for working capital and general corporate purposes.
-
All of the shares are being offered by RxSight.
-
BofA Securities is acting as the sole bookrunning manager for the offering.
For further details see:
RxSight launches $40M stock offering